ArticleBMJ open2025

Evaluating the impact of the risk-mitigation guidance for opioid prescribing in British Columbia, Canada using a cross-model comparison approach: study protocol.

Mallory J Flynn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.